Health Care & Life Sciences » Pharmaceuticals | Sunflower Pharmaceuticals Group Co. Ltd.

Sunflower Pharmaceuticals Group Co. Ltd. | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
-
331,084.90
327,515.70
339,239.90
469,858.60
607,795.20
Depreciation, Depletion & Amortization
-
73,132.00
91,562.00
134,991.80
145,102.90
145,505.20
Other Funds
202,570.00
1,197,921.90
40,394.00
18,086.50
33,415.40
3,909.70
Funds from Operations
293,543.00
436,946.60
413,621.00
469,240.20
612,268.30
739,984.70
Changes in Working Capital
-
33,493.90
299,630.70
136,387.40
45,996.60
137,659.50
Net Operating Cash Flow
293,543.00
403,452.70
113,990.30
332,852.70
566,271.70
877,644.20
Capital Expenditures
194,438.00
197,710.70
177,315.70
159,489.90
156,883.90
Sale of Fixed Assets & Businesses
357.00
883.80
705.80
3,755.70
33,307.80
Purchase/Sale of Investments
-
-
27,577.10
258,000.00
-
Net Investing Cash Flow
104,970.00
144,836.30
267,124.80
418,719.30
201,688.80
Cash Dividends Paid - Total
-
164,250.00
51,100.00
87,600.00
87,600.00
Issuance/Reduction of Debt, Net
32,903.00
61,239.70
609,190.70
126,735.50
233,663.50
Net Financing Cash Flow
235,473.00
1,094,911.60
700,684.70
57,221.90
354,678.90
Net Change in Cash
46,900.00
1,353,528.00
853,819.10
28,251.90
9,502.10
Free Cash Flow
99,105.00
205,742.10
63,325.50
173,362.90
409,387.80
Deferred Taxes & Investment Tax Credit
-
9,448.30
6,119.40
22,087.60
21,620.20
9,405.90
Net Assets from Acquisitions
-
-
96,113.50
43,000.00
82,112.60
Other Sources
89,111.00
54,079.70
33,175.80
38,684.80
4,000.00
Exchange Rate Effect
-
-
-
392.70
401.90
Other Uses
-
2,089.10
-
670.00
-

About Sunflower Pharmaceuticals Group Co.

View Profile
Address
No. 18 Donghu Road, Jizhong Area
Harbin Heilongjiang 150078
China
Employees -
Website http://www.kuihuayaoye.com
Updated 07/08/2019
Sunflower Pharmaceutical Group Co., Ltd. engages in the research and development, manufacturing, and marketing of pharmaceutical products. It focuses on proprietary Chinese medicines, chemical drugs, bio-pharmaceuticals, and tonic health care products. Its products include children's medication, digestive system medication, respiratory and cold medicine, gynecological drugs, rheumatism bone disease medication, and cardiovascular and cerebrovascular drugs.